Brandywine Global Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $28.5M | Buy |
529,009
+52,782
| +11% | +$2.54M | 0.19% | 131 |
|
|
2025
Q3 | $21.5M | Buy |
476,227
+141,494
| +42% | +$6.61M | 0.15% | 153 |
|
|
2025
Q2 | $15.5M | Sell |
334,733
-633,786
| -65% | -$31.1M | 0.11% | 191 |
|
|
2025
Q1 | $59.1M | Buy |
968,519
+20,996
| +2% | +$1.22M | 0.43% | 56 |
|
|
2024
Q4 | $53.6M | Sell |
947,523
-264,713
| -22% | -$14.8M | 0.39% | 69 |
|
|
2024
Q3 | $63.8M | Sell |
1,212,236
-17,513
| -1% | -$822K | 0.43% | 61 |
|
|
2024
Q2 | $51.1M | Sell |
1,229,749
-92,768
| -7% | -$4.15M | 0.38% | 65 |
|
|
2024
Q1 | $71.7M | Sell |
1,322,517
-106,108
| -7% | -$5.41M | 0.52% | 47 |
|
|
2023
Q4 | $73.3M | Buy |
1,428,625
+89,508
| +7% | +$4.7M | 0.59% | 41 |
|
|
2023
Q3 | $77.7M | Sell |
1,339,117
-931,401
| -41% | -$57.1M | 0.68% | 28 |
|
|
2023
Q2 | $145M | Sell |
2,270,518
-167,376
| -7% | -$11.2M | 1.21% | 9 |
|
|
2023
Q1 | $169M | Buy |
2,437,894
+117,125
| +5% | +$8.26M | 1.36% | 7 |
|
|
2022
Q4 | $167M | Buy |
2,320,769
+239,130
| +11% | +$18M | 1.3% | 11 |
|
|
2022
Q3 | $148M | Sell |
2,081,639
-170,805
| -8% | -$12.4M | 1.38% | 9 |
|
|
2022
Q2 | $173M | Buy |
2,252,444
+418,875
| +23% | +$31.9M | 1.51% | 7 |
|
|
2022
Q1 | $134M | Buy |
1,833,569
+740,694
| +68% | +$49.7M | 0.98% | 17 |
|
|
2021
Q4 | $68.1M | Buy |
1,092,875
+394,090
| +56% | +$23.1M | 0.49% | 48 |
|
|
2021
Q3 | $41.3M | Buy |
698,785
+117,132
| +20% | +$7.71M | 0.31% | 89 |
|
|
2021
Q2 | $38.9M | Buy |
581,653
+7,676
| +1% | +$501K | 0.29% | 83 |
|
|
2021
Q1 | $36.2M | Buy |
573,977
+179,226
| +45% | +$11.2M | 0.27% | 94 |
|
|
2020
Q4 | $24.5M | Sell |
394,751
-111,571
| -22% | -$6.86M | 0.2% | 130 |
|
|
2020
Q3 | $30.5M | Buy |
506,322
+7,226
| +1% | +$435K | 0.3% | 88 |
|
|
2020
Q2 | $29.3M | Sell |
499,096
-13,229
| -3% | -$791K | 0.3% | 87 |
|
|
2020
Q1 | $28.6M | Sell |
512,325
-431,255
| -46% | -$26.4M | 0.34% | 62 |
|
|
2019
Q4 | $59.8M | Sell |
943,580
-985,937
| -51% | -$56.5M | 0.42% | 61 |
|
|
2019
Q3 | $97.8M | Sell |
1,929,517
-114,485
| -6% | -$5.38M | 0.72% | 31 |
|
|
2019
Q2 | $92.7M | Buy |
2,044,002
+164,650
| +9% | +$7.67M | 0.64% | 35 |
|
|
2019
Q1 | $89.7M | Buy |
1,879,352
+85,282
| +5% | +$4.25M | 0.62% | 38 |
|
|
2018
Q4 | $93.3M | Buy |
1,794,070
+645,716
| +56% | +$34.7M | 0.69% | 36 |
|
|
2018
Q3 | $71.3M | Sell |
1,148,354
-36,732
| -3% | -$2.18M | 0.44% | 60 |
|
|
2018
Q2 | $65.6M | Buy |
+1,185,086
| New | +$64M | 0.42% | 62 |
|
|
2018
Q1 | – | Sell |
-1,078,661
| Closed | -$66.1M | – | 901 |
|
|
2017
Q4 | $66.1M | Buy |
1,078,661
+857,411
| +388% | +$53.6M | 0.39% | 67 |
|
|
2017
Q3 | $14.1M | Sell |
221,250
-7,570
| -3% | -$442K | 0.09% | 200 |
|
|
2017
Q2 | $12.8M | Buy |
+228,820
| New | +$12.5M | 0.08% | 216 |
|
|
2014
Q1 | – | Sell |
-370
| Closed | -$20K | – | 942 |
|
|
2013
Q4 | $20K | Sell |
370
-766
| -67% | -$39K | ﹤0.01% | 880 |
|
|
2013
Q3 | $53K | Sell |
1,136
-11,520
| -91% | -$506K | ﹤0.01% | 852 |
|
|
2013
Q2 | $566K | Buy |
+12,656
| New | +$549K | 0.01% | 619 |
|
Other funds holding BMY
Brandywine Global Investment Management's BMY Position: Q4 2025 in Review
Brandywine Global Investment Management increased its Bristol-Myers Squibb (BMY) stake by 11% in Q4 2025, buying an estimated $2.54M and bringing the position to 529,009 shares worth $28.5M. The position accounts for 0.19% of the portfolio, ranked #131.
Brandywine Global Investment Management first reported a position in BMY in Q2 2013 and has held it in 37 quarters since. The position peaked at $173M in Q2 2022. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Brandywine Global Investment Management held 529,009 shares of Bristol-Myers Squibb worth $28.5M as of Q4 2025.
- Brandywine Global Investment Management bought 52,782 Bristol-Myers Squibb shares in Q4 2025, an estimated $2.54M.
- Bristol-Myers Squibb made up 0.19% of Brandywine Global Investment Management's portfolio in Q4 2025, its #131 holding.
- Brandywine Global Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 37 quarters since.
- Brandywine Global Investment Management's Bristol-Myers Squibb position peaked at $173M in Q2 2022.
- 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.